Deliver Your News to the World

CybeRelease: (OTC: SFWJ) To Launch Beta Project At Anheuser-Busch


(CybeRelease, January 3, 2006) - LAKE HARMONY, PA - SES CEO, Clarisa Rojo, today announced that SES (OTC PK: SFWJ) is completing its preparations to launch a beta test of ``Effective,’’ SES’s flagship CRM software suite at Anheuser-Busch (NYSE: BUD). The Effective suite includes Customer Service, Inventory, Marketing & Sales and Mobile Solutions modules.

Following an agreement between SES and an approved supplier of Anheuser-Busch (NYSE: BUD - News), SES is making preparations to implement several applications based on SES’s Customer Relationship Management suite as a trial in Anheuser-Busch’s business units. Anheuser-Busch is a world leader in diverse operations including beer, adventure park entertainment and packaging. The beta test will first be initiated in an approved supplier of Anheuser-Busch.

``A beta test on the site of this renown, world-class company signals a promising step forward for Effective,’’ says SES CEO, Clarisa Rojo. ``Anheuser-Busch constantly strives to enhance the experience it provides to its customers and we are confident that Effective will improve all aspects of the Anheuser-Busch’s customer relationship management operations, from pre-sales through inventory updating. Anheuser-Busch is also known for its stringent supplier selection policy, and therefore we are very proud to have completed an agreement with one of its approved IT suppliers.’’

Clarisa Rojo, CEO of SES added, ``We are very confident that Anheuser-Busch will reap the benefits of the application based on Effective SES CRM infrastructure within a very short time, and the trial will pave the way for a comprehensive implementation in Anheuser-Busch’s divisions worldwide.’’
To read the complete release, go to

CybeRelease Gainers are Oscient Pharmaceuticals Corporation (Nasdaq: OSCI), Novavax, Inc. (Nasdaq: NVAX), Northfield Laboratories Inc. (Nasdaq: NFLD), Cisco Systems, Inc. (Nasdaq: CSCO), InterVoice Inc. (Nasdaq: INTV), NMS Communications Corporation (Nasdaq: NMSS), Scopus Video Networks Ltd. (Nasdaq: SCOP) and Amarin Corporation PLC (Nasdaq: AMRN).

CybeRelease Decliners are Encysive Pharmaceuticals Inc. (Nasdaq: ENCY), Inc. (Nasdaq: MAMA), McDATA Corporation (Nasdaq: MCDTA), Threshold Pharmaceuticals, Inc. (Nasdaq: THLD), Onstream Media Corporation (Nasdaq: ONSM), SciClone Pharmaceuticals, Inc. (Nasdaq: SCLN), Syntroleum Corporation (Nasdaq: SYNM) and Savient Pharmaceuticals Inc. (Nasdaq: SVNT).

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid CybeRelease $500.00 for the publication of this report. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation and do no trading of any kind.


This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.